NASDAQ:MENS Jyong Biotech (MENS) Stock Price, News & Analysis $1.77 +0.01 (+0.57%) Closing price 04:00 PM EasternExtended Trading$1.74 -0.03 (-1.98%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest About Jyong Biotech Stock (NASDAQ:MENS) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Jyong Biotech alerts:Sign Up Key Stats Today's Range$1.69▼$1.8850-Day Range$1.65▼$2.3852-Week Range$1.43▼$40.25Volume29,014 shsAverage Volume42,001 shsMarket Capitalization$134.57 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingSell Company Overview Jyong Biotech is a clinical-stage biopharmaceutical company based in Taiwan that develops treatments for urological diseases. Its research focuses on botanical drug candidates, including therapies for conditions affecting the prostate and urinary system. The company’s pipeline includes MCS-2, a botanical drug candidate being developed for benign prostatic hyperplasia, a noncancerous enlargement of the prostate. Jyong Biotech is also developing other candidates for urological conditions. Jyong Biotech was established in Taiwan and conducts drug development activities there. Its focus is on advancing its pipeline through clinical development; its candidates are investigational and are not established treatments.AI Generated. May Contain Errors. Read More Receive MENS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Jyong Biotech and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. MENS Stock News HeadlinesJyong Biotech to Host Two-Day Investor Events in Silicon Valley and Irvine, CaliforniaOctober 21, 2026 | globenewswire.comJyong Biotech Ltd. Plans to Establish Potential New Manufacturing Facility and U.S. Operations Center in TexasOctober 15, 2026 | marketscreener.comMEvery Starlink dish pays this stockThere's a chip inside every Tesla and Starlink dish that Elon doesn't own. He pays royalties to use it. Now he's filed to launch 1,000,000 AI satellites, a move Dylan believes could mean a 100X bigger royalty bill starting December 8th. This free pick names the public company collecting on every unit.November 16 at 1:00 AM | Behind the Markets (Ad)Jyong Biotech Targets BPH/LUTS Market With Proposed U.S. Manufacturing FacilityOctober 15, 2026 | rttnews.comJyong Biotech Plans Potential Texas Manufacturing Facility and U.S. Operations CenterOctober 15, 2026 | quiverquant.comQJyong Biotech Announces Proposed Texas Facility to Support Potential Commercialization of Its Drug CandidatesOctober 15, 2026 | globenewswire.comJyong Biotech Announces Participation in StockFan Virtual Investor Non-Deal RoadshowSeptember 3, 2026 | globenewswire.comJyong Biotech Ltd. Ordinary Shares (MENS)July 29, 2026 | nasdaq.comSee More Headlines MENS Stock Analysis - Frequently Asked Questions How have MENS shares performed this year? Jyong Biotech's stock was trading at $3.95 on January 1st, 2026. Since then, MENS shares have decreased by 55.2% and is now trading at $1.77. When did Jyong Biotech IPO? Jyong Biotech (MENS) raised $21 million in an initial public offering on Tuesday, June 17th 2025. The company issued 2,666,667 shares at a price of $7.50-$8.50 per share. Who are Jyong Biotech's major shareholders? Top institutional shareholders of Jyong Biotech include StoneX Group Inc. (0.02%). How do I buy shares of Jyong Biotech? Shares of MENS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Today11/16/2026Fiscal Year End12/31/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Pharmaceuticals Sub-IndustryPharmaceuticals Current SymbolNASDAQ:MENS Previous SymbolNASDAQ:MENS CIK1954488 Webwww.jyongbio.com Phone(8862) 27325205FaxN/AEmployees27Year FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value($0.33) per share Price / Book-5.36Miscellaneous Outstanding Shares76,030,000Free FloatN/AMarket Cap$134.57 million OptionableOptionable Beta2.52 Don't Wait for the OpenAI IPOThe AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.Get This Free Report This page (NASDAQ:MENS) was last updated on 11/16/2026 by MarketBeat.com Staff. From Our PartnersA $247 tool for $7Bill Poulos is offering his $247 Instant Scanner for $7 in the Black Friday sale. It's one payment for a full ...Profits Run | SponsoredWhy I'm selling my Snapback Indicator for just $7For Black Friday, Base Camp Trading's Thomas Wood is offering lifetime access to his proprietary Snapback Indi...Base Camp Trading | SponsoredEvery Starlink dish pays this stockThere's a chip inside every Tesla and Starlink dish that Elon doesn't own. He pays royalties to use it. Now...Behind the Markets | SponsoredDrop these 5 stocks before the market opens tomorrow!The Wall Street Journal called it the "$64 trillion question": is a stock market crash on the way? Weiss Ratin...Weiss Ratings | SponsoredWhat the hell is going on?Porter Stansberry says President Trump is quietly replacing the U.S. dollar without a vote in Congress, and th...Porter & Company | SponsoredYour Copy is on Hold (Claim it now)James Altucher, who called NVIDIA in 2008 and SpaceX years before a single share traded, has a new report on E...Paradigm Press | SponsoredIntel Shares Jumped 177% After Elon Musk's DealElon Musk's April 2026 partnership with Intel sent shares climbing 177% within two months. Jeff Brown, the ...Brownstone Research | SponsoredSmall-Cap SMX is Taking its Technology into Multiple Trillion-Dollar Industries!SMX (NASDAQ: SMX) uses proprietary molecular-marking technology and a Digital Material Passport platform to gi...Smallcaps Daily | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Jyong Biotech Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Jyong Biotech With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.